CHEK2 and neoplasm: It remains uncertain whether this reflects two different tumor groups, i.e. one with complete loss of wild type CHEK2 and thereby CHEK2 driven tumorigenesis and one without thereby representing sporadic tumors, or that loss of one CHEK2 allele is sufficient to drive tumorigenesis.